Literature DB >> 20359779

Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease.

Uma S Yezhuvath1, Jinsoo Uh, Yamei Cheng, Kristin Martin-Cook, Myron Weiner, Ramon Diaz-Arrastia, Matthias van Osch, Hanzhang Lu.   

Abstract

Epidemiologic evidence and postmortem studies of cerebral amyloid angiopathy suggest that vascular dysfunction may play an important role in the pathogenesis of Alzheimer's disease (AD). However, alterations in vascular function under in vivo conditions are poorly understood. In this study, we assessed cerebrovascular-reactivity (CVR) in AD patients and age-matched controls using CO(2)-inhalation while simultaneously acquiring Blood-Oxygenation-Level-Dependent (BOLD) MR images. Compared with controls, AD patients had widespread reduction in CVR in the rostral brain including prefrontal, anterior cingulate, and insular cortex (p < 0.01). The deficits could not be explained by cardiovascular risk factors. The spatial distribution of the CVR deficits differed drastically from the regions of cerebral blood flow (CBF) deficits, which were found in temporal and parietal cortices. Individuals with greater CVR deficit tended to have a greater volume of leukoaraiosis as seen on FLAIR MRI (p = 0.004). Our data suggest that early AD subjects have evidence of significant forebrain vascular contractility deficits. The localization, while differing from CBF findings, appears to be spatially similar to PIB amyloid imaging findings.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359779      PMCID: PMC2896562          DOI: 10.1016/j.neurobiolaging.2010.02.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  47 in total

1.  Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study.

Authors:  E Rostrup; I Law; M Blinkenberg; H B Larsson; A P Born; S Holm; O B Paulson
Journal:  Neuroimage       Date:  2000-02       Impact factor: 6.556

2.  Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging.

Authors:  D C Alsop; J A Detre; M Grossman
Journal:  Ann Neurol       Date:  2000-01       Impact factor: 10.422

3.  Quantification of cerebral blood flow by bolus tracking and artery spin tagging methods.

Authors:  T Q Lia; Z Guang Chen; L Ostergaard; T Hindmarsh; M E Moseley
Journal:  Magn Reson Imaging       Date:  2000-06       Impact factor: 2.546

4.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

Review 5.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

6.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Authors:  G W Small; L M Ercoli; D H Silverman; S C Huang; S Komo; S Y Bookheimer; H Lavretsky; K Miller; P Siddarth; N L Rasgon; J C Mazziotta; S Saxena; H M Wu; M S Mega; J L Cummings; A M Saunders; M A Pericak-Vance; A D Roses; J R Barrio; M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

7.  Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.

Authors:  J S Meyer; G M Rauch; R A Rauch; A Haque; K Crawford
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

8.  Reduced vasomotor reactivity in cerebral microangiopathy : a study with near-infrared spectroscopy and transcranial Doppler sonography.

Authors:  C Terborg; F Gora; C Weiller; J Röther
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

Review 9.  Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

Authors:  M M Breteler
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

10.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

View more
  50 in total

1.  Comparison of relative cerebral blood flow maps using pseudo-continuous arterial spin labeling and single photon emission computed tomography.

Authors:  Peiying Liu; Jinsoo Uh; Michael D Devous; Bryon Adinoff; Hanzhang Lu
Journal:  NMR Biomed       Date:  2011-12-02       Impact factor: 4.044

2.  Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge.

Authors:  S Chawla; Y Ge; H Lu; O Marshall; M S Davitz; G Fatterpekar; B J Soher; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

3.  A Pilot Study of Changes in Medial Temporal Lobe Fractional Amplitude of Low Frequency Fluctuations after Sildenafil Administration in Patients with Alzheimer's Disease.

Authors:  Niyatee Samudra; Michael Motes; Hanzhang Lu; Min Sheng; Ramon Diaz-Arrastia; Michael Devous; John Hart; Kyle B Womack
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Bolus arrival time and cerebral blood flow responses to hypercarbia.

Authors:  Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

5.  Imaging of Cerebrovascular Function in Chronic Traumatic Brain Injury.

Authors:  Franck Amyot; Kimbra Kenney; Carol Moore; Margalit Haber; L Christine Turtzo; Christian Shenouda; Erika Silverman; Yunhua Gong; Bao-Xi Qu; Leah Harburg; Hanzhang Y Lu; Eric M Wassermann; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2018-03-20       Impact factor: 5.269

6.  Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.

Authors:  Min Sheng; Hanzhang Lu; Peiying Liu; Yang Li; Harshan Ravi; Shin-Lei Peng; Ramon Diaz-Arrastia; Michael D Devous; Kyle B Womack
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

8.  Life-long aerobic exercise preserved baseline cerebral blood flow but reduced vascular reactivity to CO2.

Authors:  Binu P Thomas; Uma S Yezhuvath; Benjamin Y Tseng; Peiying Liu; Benjamin D Levine; Rong Zhang; Hanzhang Lu
Journal:  J Magn Reson Imaging       Date:  2013-03-22       Impact factor: 4.813

Review 9.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 10.  Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

Authors:  Edith Hamel; Jessika Royea; Brice Ongali; Xin-Kang Tong
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.